Latest Clario News & Updates
See the latest news and media coverage for Clario. We track all announcements, press releases, and industry mentions in real time, all in one place.
Clinical trial endpoint technology and services provider
clario.com- Headquarters
- Philadelphia, United States
- Founded year
- 1972
- Company type
- Public company
- Number of employees
- 1,000–7,500
Last updated
Latest news about Clario
In short: Clario was acquired by Thermo Fisher Scientific for $8.875 billion, strengthening its position as a leader in AI-enabled clinical trial solutions.
Company announcements
-
Clario study shows speech-latency biomarker strengthens schizophrenia trial separation
Research in Biological Psychiatry reveals excluding high placebo responders via speech latency boosts drug-placebo separation 2-3 times in brilaroxazine Phase III trial. Clario’s Chief Research Officer Mark Opler co-investigated.
-
Clario achieves ISO 42001 certification for AI management
The certification, audited by Schellman, underscores Clario's leadership in responsible AI for clinical trials, complementing ISO 27701 and 27001 standards.
-
NICE publishes draft guidance recognizing Clario's AI-supported spirometry
The guidance highlights ArtiQ.Spiro's potential to enable high-quality testing in primary care, expand access, and reduce waiting times.
-
Clario announces Gaurav Josan's Responsible Tech Leader Award win
He received it at the 2025 WLDA Awards Gala for embedding transparency, ethics, and equity in AI systems. His work advances responsible AI in clinical trials.
Media coverage
-
CLARIO GROUP LAUNCHES XROI™, A PROPRIETARY AI-ENABLED FRAMEWORK FOR EVALUATING EXECUTIVE REPUTATION,...
XROI™ anchors a broader suite of AI-powered solutions designed to elevate leadership performance and organizational impactNEW YORK, April 27, 2026 /PRNewswire/ -- Clario Group today...
-
Thermo Fisher lifts 2026 forecast after Clario deal, AI tie-ups
Thermo Fisher Scientific raised its 2026 revenue forecast to $47.3-$48.1 billion and adjusted EPS to $24.64-$25.12 after a strong first quarter and the completion of...
-
Thermo Fisher nears US$10 billion takeover of Clario, FT reports
BENGALURU: Medical equipment maker Thermo Fisher is nearing an all-cash takeover of US-based Clario in a deal that could value the clinical trial data management...
-
Thermo Fisher Completes Strategic Acquisition of Clario Holdings
Thermo Fisher ( (TMO)) just unveiled an announcement. On March 24, 2026, Thermo Fisher Scientific announced it had completed the $8.875 billion cash acquisition of...
Track Clario and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore